SCHEMBL4401258

SCHEMBL4401258

C[Si](C)(CCC1CC2C=CC1C2)O[Si](O[Si](C)(C)CCC1CC2C=CC1C2)(O[Si](C)(C)CCC1CC2C=CC1C2)O[Si](C)(C)CCC1CC2C=CC1C2

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
HTT P42858 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL416791 0.93 KDM4E (0.40) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL23911750 0.93 KDM4E (0.40) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL7526586 0.90 KDM4E (0.38) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL1221875 0.90 KDM4E (0.38) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL16418948 0.86 ALDH1A1 (0.36) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL29325829 0.86 ALDH1A1 (0.36) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL1760598 0.85 KDM4E (0.39) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL29326148 0.84 ALDH1A1 (0.35) KDM4EALDH1A1MEN1KMT2A
SCHEMBL29326152 0.84 ALDH1A1 (0.35) KDM4EALDH1A1MEN1KMT2A
SCHEMBL29326136 0.84 ALDH1A1 (0.35) KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094760-B1 COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD 3M INNOVATIVE PROPERTIES CO (US) 2017-05-31 EP disclosed
US-8431625-B2 Compositions curable by ring opening metathesis polymerization at low temperatures and their application in the dental field 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-04-30 US disclosed
US-8178604-B2 Solid materials obtainable by ring-opening metathesis polymerization 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-05-15 US disclosed
US-20100036015-A1 COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD 3M INNOVATIVE PROPERTIES COMPANY 2010-02-11 US disclosed
US-20090088494-A1 SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION 3M INNOVATIVE PROPERTIES COMPANY 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100036015-A1 COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD DNMT3B, HMBS, MMAB KDM4E 3465/4885ALDH1A1 454/4885MEN1 784/4885
US-20090088494-A1 SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION MMAB, DNMT3B, RHEB KDM4E 1902/4885ALDH1A1 4132/4885MEN1 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.